Bone marrow- and subcutaneous adipose tissue-derived mesenchymal stem cells: Differences and similarities

Cell Cycle

Volumn 11, Issue 2, 2012, Pages 377-383

  Dmitrieva, Renata I ^a   Minullina, R ^a   Bilibina, Anna A ^a   Tarasova, Olga V ^a   Anisimov, Sergey V ^a   Zaritskey, Andrey Y ^a  

^a ALMAZOV NATIONAL MEDICAL RESEARCH CENTRE   (Russian Federation)

Author keywords

Adipose tissue derived mesenchymal stem cells; Bone marrow derived mesenchymal stem cells; Colony forming units (CFU F); Differentiation; IL6; MCP1; Proliferation; SDF 1; Senescence; TGF 1; VEGF

Indexed keywords

INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; STROMAL CELL DERIVED FACTOR 1; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ADIPOSE TISSUE; ARTICLE; BONE MARROW; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; COLONY FORMING UNIT F; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; MESENCHYMAL STEM CELL; SENESCENCE; SUBCUTANEOUS FAT;

EID: 84856105891     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.11.2.18858     Document Type: Article

References (36)

1. Trachtenberg B, Velazquez DL, Williams AR, McNiece I, Fishman JM, Nguen K, et al. Rationale and design of the transendocardial injection of autologous human cells (bone marrow or mesenchymal) in chronic ischemic left Ventricular dysfunction and heart failure secondary to myocardial infarction (TAC-HFT) trial: a randomized, double-blind, placebo-controlled study of safety and efficacy. Am Heart J 2011; 161:487-93; PMID:21392602; http://dx.doi.org/10.1016/ j.ahj.2010.11.024.
2. Mishra PK. Bone marrow-derived mesenchymal stem cells for treatment of heart failure: is it all paracrine actions and immunomodulation? J Cardiovasc Med (Hagerstown) 2008; 9:122-8; PMID:18192802; http://dx.doi.org/10.2459/JCM. 0b013e32820588f0.
3. Hatzistergos KE, Quevedo H, Oskouei BN, Hu Q, Feigenbaum GS, Margitich IS, et al. Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circ Res 2010; 107:913-22; PMID:20671238; http://dx.doi.org/10.1161/CIRCRESAHA.110.222703.
4. Miyahara Y, Nagaya N, Kataoka M, Yanagawa B, Tanaka K, Hao H, et al. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med 2006; 12:459-65; PMID:16582917; http://dx.doi.org/10.1038/ nm1391.
5. Shabbir A, Zisa D, Suzuki G, Lee T. Heart failure therapy mediated by the trophic activities of bone marrow mesenchymal stem cells: a noninvasive therapeutic regimen. Am J Physiol Heart Circ Physiol 2009; 296:1888-97; PMID:19395555; http://dx.doi.org/10.1152/ajpheart.00488.2010.
6. Quevedo HC, Hatzistergosa KE, Oskouei BN, Feigenbauma GS, Rodrigueza JE, Valdesa D, et al. Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proc Natl Acad Sci USA 2009; 106:14022-7; PMID:19666564; http://dx.doi. org/10.1073/pnas.0903201106.
7. Hare JM, Traverse JH, Henry TD, Dib N, Strumpf RK, Schulman SP, et al. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol 2009; 54:2277-86; http://dx.doi.org/10. 1016/j.jacc.2009.06.055.
8. Segers VF, Lee RT. Stem-cell therapy for cardiac disease. Nature 2008; 451:937-42; PMID:18288183; http://dx.doi.org/10.1038/nature06800.
9. Gersh BJ, Simari RD, Behfar A, Terzic CM, Terzic A. Cardiac Cell Repair Therapy: A Clinical Perspective. Mayo Clin Proc 2009; 84:876-92; PMID:19797777; http://dx.doi.org/10.4065/84.10.876.
10. Phinney DG, Prockop D. Concise review: Mesenchymal stem/multipotent stromal cells: The state of trans-differentiation and modes of tissue repair - current views. Stem Cells 2007; 25:2896-902; PMID:17901396; http://dx.doi.org/ 10.1634/stemcells.2007-0637.
11. Kelly SS, Sola CBS, de Lima M, Shpall E. Ex vivo expansion of cord blood. Bone Marrow Transplant 2009; 44:673-81; PMID:19802023; http://dx.doi.org/10. 1038/bmt.2009.284.
12. Vidal MA, Walker N, Napoli E, Borjesson D. Evaluation of Senescence in Mesenchymal Stem Cells Isolated from Equine Bone Marrow, Adipose Tissue and Umbilical Cord Tissue. Stem Cells Dev 2011; In press; PMID:21410356; http://dx.doi.org/10.1089/scd.2010.0589.
13. Bianco P, Robey PG, Simmons PJ. Mesenchymal stem cells: revisiting history, concepts and assays. Cell Stem Cell 2008; 2:313-9; PMID:18397751; http://dx.doi.org/10.1016/j.stem.2008.03.002.
14. Zhang M, Mal N, Kiedrowski M, Chacko M, Askari AT, Popovic ZB, et al. SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction. FASEB J 2007; 21:3197-207; PMID:17496162; http://dx.doi.org/10.1096/fj.06-6558com.
15. Charbord P. Bone marrow mesenchymal stem cells: historical overview and concepts. Hum Gene Ther 2010; 21:1045-56; PMID:20565251; http://dx.doi.org/10. 1089/hum.2010.115.
16. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284:143-7; PMID:10102814; http://dx.doi.org/10.1126/science.284.5411.143.
17. Kastrinaki MC, Andreakou I, Charbord P, Papadaki HA. Isolation of human bone marrow mesenchymal stem cells using different membrane markers: comparison of colony/cloning efficiency, differentiation potential and molecular profile. Tissue Eng Part C Methods 2008; 14:333-9; PMID:18800875; http://dx.doi.org/10. 1089/ten.tec.2008.0173.
18. Bianco P, Robey PG. Skeletal stem cells. In Cells Lanza RP, Ed. Handbook of Adult and Fetal Stem. San Diego, CA: Academic Press 2004; 415-24.
19. Gronthos S, Zannettino AC, Hay SJ, Shi S, Graves SE, Kortesidis A, et al. Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J Cell Sci 2003; 116:1827-35; PMID:12665563; http://dx.doi.org/10.1242/jcs.00369.
20. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8:315-7; PMID:16923606; http://dx.doi.org/10.1080/14653240600855905.
21. Sacchetti B, Funari A, Michienzi S, Di Cesare S, Piersanti S, Saggio I, et al. Self-Renewing Osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 2007; 131:324-36; PMID:17956733; http://dx.doi.org/10.1016/j.cell.2007.08.025.
22. + multipotent mesenchymal stromal cells. Exp Hematol 2008; 36:1035-46; PMID:18504067; http://dx.doi.org/10.1016/j.exphem.2008.03.004.
23. Li L, Zhang S, Zhang Y, Yu B, Xu Y, Guan Z. Paracrine action mediate the antifibrotic effect of transplanted mesenchymal stem cells in a rat model of global heart failure. Mol Biol Rep 2009; 36:725-31; PMID:18368514; http://dx.doi.org/10.1007/s11033-008-9235-2.
24. Markel TA, Wang Y, Herrmann JL, Crisostomo PR, Wang M, Novotny NM, et al. VEGF is critical for stem cell-mediated cardioprotection and a crucial paracrine factor for defining the age threshold in adult and neonatal stem cell function. Am J Physiol Heart Circ Physiol 2008; 295:2308-14; PMID:18849336; http://dx.doi.org/10.1152/ajpheart.00565.2008.
25. Guzman MJ, Crisostomo PR, Wang M, Markel TA, Wang Y, Meldrum DR. Vascular Endothelial Growth Factor Improves Myocardial Functional Recovery Following Ischemia/Reperfusion Injury. J Surg Res 2008; 150:286-92; PMID:18619619; http://dx.doi.org/10.1016/j.jss.2007.12.772.
26. Mirotsou M, Jayawardena TM, Schmeckpeper J, Gnecchi M, Dzau VJ. Paracrine mechanisms of stem cell reparative and regenerative actions in the heart. J Mol Cell Cardiol 2011; 50:280-9; PMID:20727900; http://dx.doi.org/10.1016/j.yjmcc. 2010.08.005.
27. Kachgal S, Putnam AJ. Mesenchymal stem cells from adipose and bone marrow promote angiogenesis via distinct cytokine and protease expression mechanisms. Angiogenesis 2011; 14:47-59; PMID:21104120; http://dx.doi.org/10.1007/s10456- 010-9194-9.
28. Bonab MM, Alimoghaddam K, Talebian F, Ghaffari SH, Ghavamzadeh A, Nikbin B. Aging of mesenchymal stem cell in vitro. BMC Cell Biol 2006; 7:14; PMID:16529651; http://dx.doi.org/10.1186/1471-2121-7-14.
29. Baxter MA, Wynn RF, Jowitt SN, Wraith JE, Fairbairn LJ, Bellantuono I. Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion. Stem Cells 2004; 22:675-82; PMID:15342932; http://dx.doi.org/10.1634/stemcells.22-5-675.
30. Banfi A, Muraglia A, Dozin B, Mastrogiacomo M, Cancedda R, Quarto R. Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: Implications for their use in cell therapy. Exp Hematol 2000; 28:707-15; PMID:10880757; http://dx.doi.org/10.1016/S0301-472X(00) 00160-0.
31. Wagner W, Horn P, Castoldi M, Diehlmann A, Bork S, Saffrich L, et al. Replicative Senescence of Mesenchymal Stem Cells: A Continuous and Organized Process. PLoS ONE 2008; 3:2213; PMID:18493317; http://dx.doi.org/10.1371/ journal.pone.0002213.
32. Tsai CC, Chen YJ, Yew TL, Chen LL, Wang JY, Chiu CH, et al. Hypoxia inhibits senescence and maintains mesenchymal stem cell properties through downregulation of E2A-p21 by HIF-TWIST. Blood 2011; 117:459-69; PMID:20952688; http://dx.doi.org/10.1182/blood-2010-05-287508.
33. Harrison JS, Rameshwar P, Chang V, Bandari P. Oxygen saturation in the bone marrow of healthy volunteers. Blood 2002; 99:394; PMID:11783438; http://dx.doi.org/10.1182/blood.V99.1.394.
34. Cristofalo VJ, Allen RG, Pignolo RJ, Martin BG, Beck JC. Relationship between donor age and the replicative lifespan of human cells in culture: a reevaluation. Proc Natl Acad Sci USA 1998; 95:10614-9; PMID:9724752; http://dx.doi.org/10.1073/pnas.95.18.10614.
35. Mitchell JB, Mcintosh K, Zvonic S, Garrett S, Floyd ZE, Kloster A, et al. Immunophenotype of human adipose-derived cells: temporal changes in stromal-associated and stem cell-associated markers. Stem Cells 2006; 24:376-85; PMID:16322640; http://dx.doi.org/10.1634/stemcells.2005-0234.
36. Roth V. 2006; http;//www.doubling-time.com/compute.php